Indianapolis, IN, United States of America

Michael Gregory Bell

This inventor holds 22 USPTO granted patents and 2 published patent applications and 4 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Eli Lilly and Company, Other. Active years: 1990-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Gregory Bell. Retrieved from https://idiyas.com/inventor/michael-gregory-bell

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 22 (Patent Applications = 2)

% Patents Active = 81.8

EPO Patents = 4 (Patent Applications = 2)

Average Co-Inventor Count = 5.4

ph-index = 8

Forward Citations = 149(Granted Patents)

Location History:

Bellflower, CA (US) (1990)
Downey, CA (US) (1998)
Indianapolis, IN (US) (1998 - 2012)
Fishers, IN (US) (2014)

Company Filing History:

20 out of 4,517

Eli Lilly and Company

patents

2 out of 834,601

Other

patents

Years Active: 1990-2026

Loading Chart...

Areas of Expertise:

Glucagon-Like Peptide

Aldosterone Synthase

FXR Modulators

Dyslipidemia Treatment

Steroid Hormone

Iglur5 Antagonists

Beta-3 Adrenergic Agonists

Benzo Compounds

Position Sensing

Clamping Means

Selective Receptor

Nuclear Receptor

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12735433 - Macrocyclic glucagon-like peptide 1 receptor agonists (2026-09-15),

2. 8778984 - Aldosterone synthase inhibitor (2014-07-15),

3. 8106077 - Compounds and methods for modulating FXR (2012-01-31),

4. 7863302 - Compounds and methods for modulating FX-receptors (2011-01-04),

5. 7846960 - FXR agonists (2010-12-07),

6. 7470705 - Compounds and methods for treating dyslipidemia (2008-12-30),

7. 7411072 - Tricyclic steroid hormone nuclear receptor modulators (2008-08-12),

8. 6579886 - Selective iglur5 receptor antagonists (2003-06-17),

9. 6265581 - Selective &bgr;3 adrenergic agonists (2001-07-24),

10. 6133458 - Benzo[B]indeno[2, 1-D]thiophene compounds, intermediates, compositions, (2000-10-17),

11. 6093735 - Selective .beta.-3 adrenergic agonists (2000-07-25),

12. 6075040 - Selective .beta..sub.3 adrenergic agonists (2000-06-13),

13. 6060492 - Selective .beta.3 adrenergic agonists (2000-05-09),

14. 5977154 - Selective .beta.3 adrenergic agonist (1999-11-02),

15. 5939443 - Selective .beta.3 adrenergic agonists (1999-08-17),

Title: The Innovative Journey of Michael Gregory Bell

Introduction: Michael Gregory Bell, a visionary inventor based in Indianapolis, IN, has made significant contributions to the field of technology with his groundbreaking inventions.

Latest Patents: Michael Gregory Bell holds several patents in various technological domains, including artificial intelligence, renewable energy, and medical devices.

Career Highlights: With a career spanning over two decades, Michael Gregory Bell has established himself as a leading figure in the innovation landscape. His work has been recognized for its creativity and practicality, earning him numerous accolades in the industry.

Collaborations: Throughout his career, Michael Gregory Bell has collaborated with top research institutions, universities, and leading companies to bring his inventions to life. His ability to work across disciplines has led to the development of cutting-edge technologies that have had a lasting impact.

Conclusion: Michael Gregory Bell's passion for innovation and his relentless pursuit of excellence continue to drive him towards creating solutions that shape the future of technology. His inventive spirit and dedication to making a difference make him a true pioneer in the world of inventions.

Profile summary based on public USPTO records.